Latest Medtech News
From AI-driven robotics and autonomous surgery to digital health and precision diagnostics, this week’s MedTech funding rounds underscore the acceleration of technologies designed to improve clinical decision-making, accessibility and patient outcomes. Read the full updates below.
As an executive search partner to the MedTech industry, Guided Solutions keeps a close eye on stories like these. Subscribe to our Industry Insights for weekly coverage.
Carvolix secures €30M debt financing to accelerate AI-driven robotics commercialization
Carvolix has secured up to €30M in structured debt financing from Claret Capital, including an initial €10M drawdown. The funding will support commercialization and industrialization of its AI-driven robotic platforms, including the FDA 510(k)-pending Tavipilot robotic system for cardiovascular interventions and the Kalios implant platform.
CEO Sébastien Ladet: "Claret Capital’s interest in our technology and roadmap is a further validation as we work to make AI-driven robotics and biomimetic implants a new standard of care for patients facing complex cardiovascular and neurovascular procedures.”
Andromeda Surgical raises $15M Series A to advance autonomous surgery platform
Andromeda Surgical secured $15M Series A funding led by Standard Capital to accelerate development of its autonomous surgical platform, starting with endourology procedures. The company’s system has already supported HoLEP procedures across three countries and will expand commercialization following regulatory clearances.
Co-founder and CEO Nick Damiano: “Globally, five billion people lack access to safe, affordable surgical care when they need it. Our goal is to solve both problems: first, by helping surgeons treat more patients at a consistently higher standard, and ultimately, by bringing expert surgery to places where it barely exists today."
Salus Scientific raises $10.1M Series A to support commercial expansion
Salus Scientific has raised $10.1M in an oversubscribed Series A financing to accelerate commercial scale-up, expand production capabilities and strengthen clinical infrastructure. The funding will support the company’s next phase of growth and revenue expansion.
Chairman and CEO Todd Flohr: “We are thrilled to welcome partners who understand our value proposition and align with the company's long-term vision. That the round closed oversubscribed is, in our view, a direct endorsement of both our commercial thesis and our execution discipline.”
Wellinks secures $10M for respiratory disease RPM tool’s advancement
Wellinks secured $10M to scale its FDA-cleared Spire RPM platform, which uses wearable technology to monitor respiratory health and support earlier intervention for chronic conditions. Funds will drive commercial expansion, clinical data growth, and broader cardiopulmonary applications.
COO and interim CEO Jennifer Barretta: “This investment represents validation of the solution we’ve built and the outcomes it delivers.”
Vexev raises $6M to advance autonomous vascular imaging platform in the US
Vexev secured $6M to accelerate FDA clearance and U.S. commercialization of VxWave, its robotic AI-powered ultrasound platform designed to standardize vascular imaging. Following successful clinical validation in dialysis workflows, the funding will support regulatory activities, manufacturing scale-up, and market expansion.
“We are starting with dialysis patients because the clinical need is clear, but our vision is much broader: to build an autonomous imaging platform that helps clinicians make faster, more consistent and more informed decisions across vascular disease.”
Meduloc raises $4M Series B to advance flexible fracture fixation platform
Meduloc secured $4M Series B financing to support the controlled commercial launch of its FDA-cleared nitinol intramedullary implant for orthopedic fracture fixation. The funding will accelerate clinical evidence generation and expansion of its platform across adult and pediatric fracture care.
President and CEO Sarah Sachinis: "Closing this financing is a significant milestone for Meduloc as we move from product development and regulatory clearance into controlled commercialization,"
MammoCheck secures €500K grant to advance AI-powered breast cancer screening platform
MammoCheck received a €500K SEED programme grant from Cyprus’ Research and Innovation Foundation to support clinical, quality, and regulatory efforts toward FDA clearance and CE marking for its AI-enabled thermal imaging platform designed to support breast cancer screening.
Co-Founder and CEO Alexandra Dimitriadou
Elehear raises Pre-A funding to advance AI-powered hearing technology
Elehear secured tens of millions of yuan in Pre-A financing led by Oriza Puhua to accelerate AI-driven audio technology development, product innovation, and global expansion. The company focuses on speech enhancement, personalized sound processing, and smart hearing solutions.
Founder and CEO Eric Miao
CND Life Sciences secures growth financing to expand neurodiagnostics platform
CND Life Sciences raised growth financing led by S-Curve Partners to accelerate adoption of its Syn-One Test platform, a skin biopsy-based biomarker test supporting diagnosis of Parkinson’s disease and other neurodegenerative disorders. Funds will support commercial expansion, product innovation, and broader precision neurology initiatives.
CEO Rick Morello: “We are pleased to deepen our relationship with S-Curve Partners and grateful for the continued support of existing investors and shareholders,”
